Lululab, an AI beauty and healthcare company using skin data, said it would jointly target the Southeast Asian digital healthcare market with a Vietnamese partner.The company signed a memorandum of understanding with Hanoi Medical University (HMU) to develop an AI analytic solution for skin disease
Daewoong Pharmaceutical said it posted sales of 293.8 billion won ($226.3 million) and an operating profit of 33.6 billion won in the second quarter, up 7.6 percent and 25.8 percent from a year ago.Daewoong renewed its three-month profit record in the two consecutive quarters and saw its sales soar
Korean doctors’ prescription rate of antibiotics to treat colds plunged to 35 percent in 2021 from 73 percent in 2002, according to a report released Friday by the Health Insurance Review and Assessment Service (HIRA).Tertiary general hospitals’ antibiotics prescription rate for a cold remained at a
As drinkable liquid formulation dementia treatments have won domestic approval, attention is drawn to what effects they will have on the market, industry insiders said Thursday.The Ministry of Food and Drug Safety recently approved Genuone Sciences’ Keicept 5 mg (ingredient: donepezil hydrochloride)
The U.S. Food and Drug Administration has approved the application to expand indications for Enhertu (ingredient: trastuzumab deruxtecan) submitted by Daiichi Sankyo and AstraZeneca, industry sources said Thursday.That means the FDA will decide whether to permit its use for HER2-low metastatic breas
Samsung Biologics said Wednesday it surpassed 1 trillion won in sales ($768 million) in the first half-year for the first time since its foundation, thanks to the rapid growth of its contract manufacturing organization business.In the second quarter, the company recorded 651.4 billion in sales and 1
Astellas Korea said Wednesday that its prostate cancer treatment, Xtandi, (ingredient name: enzalutamide), will be covered by selective benefits in treating hormone-responsive metastatic prostate cancer (mHSPC) combined with androgen deprivation therapy (ADT).Xtandi is a prostate cancer treatment wi
ISU Abxis said Wednesday that it signed a contract to supply up to 14 billion won ($10.7 million) of gaucher disease treatment, Abcertin, with Algeria’s Pharmacy Central Hospital (PCH).PCH is an institution that exclusively procures medicines and medical supplies for all public hospitals in Algeria.
Jeil Pharmaceutical announced on Thursday that it has signed a domestic exclusive supply contract of cefiderocol, a super-antibiotics of Ping An-Shionogi based on the siderophore cephalosporin antibiotic component.Ping An-Shionogi, a joint corporation of Japan’s Shionogi and Hong Kong’s Ping An, has
Hanmi Pharmaceutical said it has completed preparations for product release, as it has become the first Korean company to win all four patent suits concerning the use patent of Entresto, Novartis’ chronic heart failure treatment.Hanmi, also the first in Korea to meet requirements for priority sales
The stock prices of Korean pharmaceutical companies developing Alzheimer's disease treatment dropped as suspicions arose about the possible manipulation of a research paper on amyloid beta, a key substance in dementia treatment.Cellivery Therapeutics, a company developing iCP-Parkin, a Parkinson's d
Hugel’s botulinus toxin medication, Botulax (Letybo), has proved to be effective in improving furrows between eyebrows through phase 3 clinical trials in the U.S. and Europe, the company said Tuesday.It added that the trial results were published in the June issue of Aesthetic Surgery Journal.Accord
Investors should pay attention to the fact that Daewoong Pharmaceutical is strengthening its R&D capabilities and showing results, an analyst said Tuesday.Kwon Hae-soon, a Eugene Investment analyst, noted that Daewoong's corporate value had been discounted in the stock market due to its lack of abil
Deargen, an artificial intelligence-based pharma-tech company, said on Tuesday that it began the full-scale operation of the iDear Center, an institute for AI convergence development and research of new drugs.The center in Dongtan, Gyeonggi-do, is the largest wet lab run by domestic artificial intel
Daewoong Pharmaceutical said on Tuesday that it has completed a phase 1 clinical trial of IVL3001(ingredient name: finasteride), a hair loss treatment injection, in Australia in collaboration with Inventage Lab and Withus Pharmaceutical.The first phase of the IVL3001 clinical trial proved stable blo
Hyundai Bioscience said Monday that it received positive reviews on the first round of phase 2 clinical trial of its CP-COV03, the first general-purpose Covid-19 treatment worldwide, from the Data & Safety Monitoring Board (DSMB).The DSMB is organized on a per-clinical basis, in which independent ex
Humasis, a company specializing in rapid on-site inspection, said it had obtained the Canadian Personal CE certification for its Covid-19 self-test kits.The company’s Covid-19 Ag Home Test was also certified and officially approved in Korea. Amid reviving demand for personal inspection kits due to t
The World Health Organization’s training program to turn Korea into a global hub to cultivate a bio workforce has begun in earnest.GC Biopharma said it conducted the ‘2022 Introductory Course for Biologics Development and Manufacturing’ under the auspices of the International Vaccine Institute (IVI)
Bristol Myers Squibb (BMS) Korea said it has appointed Lee He-young, the country manager of Viatris Korea, as its new CEO.According to industry sources, the current BMS Korea CEO, Kim Jin-young, has recently been appointed as the head of BMS’ global compliance organization and decided to recruit Lee
MSD said Friday it expects the expanded indication of anti-PD-1 therapy Keytuda (pembrolizumab) as neoadjuvant therapy for triple-negative breast cancer (TNBC) to resolve unmet needs and help patients return to normal life early.The company added that it won expanded indication to be used as neoadju